Best Surgical Gastroenterologists for Pancreatic Cancer Surgery in India

Pancreatic cancer is a malignancy that originates in the cells of the pancreas, most commonly in the ducts that carry digestive enzymes. Because it rarely causes obvious symptoms in its early stages, it is frequently detected only after it has reached a locally advanced or metastatic stage.

Common presentations include persistent upper abdominal or back pain, unexplained weight loss, new-onset or worsening diabetes, jaundice (yellowing of the skin and eyes, often accompanied by dark urine and pale stools when the bile duct is obstructed), and loss of appetite or fatigue. Less specific signs such as nausea, changes in stool consistency, or a new blood-clot event can also occur. These symptoms overlap with many other conditions, so experiencing them does not confirm a diagnosis — a structured clinical and radiological assessment is required.

Diagnosis typically begins with cross-sectional imaging, most commonly a contrast-enhanced CT scan of the abdomen and chest, which helps define the size and location of the tumour and whether it involves major blood vessels (a key factor in determining resectability). MRI or endoscopic ultrasound (EUS) may be used for additional detail or to obtain a tissue biopsy, and PET-CT is sometimes performed to detect distant spread. The serum tumour marker CA 19-9 can support clinical decision-making but is not diagnostic on its own; staging follows the TNM system and places tumours into categories — resectable, borderline resectable, locally advanced, or metastatic — that directly shape treatment planning.

The appropriate treatment pathway depends on tumour stage, the patient's overall health, and whether the cancer involves critical vascular structures. Surgical resection — such as a Whipple procedure (pancreaticoduodenectomy) for tumours in the head of the pancreas, or a distal pancreatectomy for body and tail tumours — offers the best chance of long-term disease control when the cancer is confined and technically removable. For cancers that cannot be removed surgically, options include chemotherapy regimens (such as FOLFIRINOX or gemcitabine-based combinations), radiation-based approaches including Stereotactic Body Radiation Therapy (SBRT), or a combination of these; all treatment decisions should be made by a multidisciplinary team based on individual assessment.

Many patients with pancreatic cancer — particularly those with locally advanced or metastatic disease, or those whose overall health makes surgery high-risk — are managed with systemic chemotherapy, targeted therapy (where a specific mutation such as BRCA is present), or immunotherapy within a clinical trial. SBRT can be used to treat tumours that are locally advanced but not amenable to surgery, either as a primary approach or to downstage the tumour before reassessing surgical eligibility. Supportive and palliative care — including pain management, nutritional support, and enzyme replacement therapy for pancreatic insufficiency — is an important part of care at every stage and is not a lesser alternative; it runs alongside active treatment or, when appropriate, becomes the primary focus.

Pancreatic cancer surgery may be considered only when it is appropriate for the confirmed diagnosis and the expected benefit outweighs the individual risks. The decision may depend on symptom severity, investigation results, previous treatment, overall health and the patient's goals. A specialist should discuss alternatives and recovery before any procedure is planned.

Pancreatic cancer is typically evaluated and managed by a multidisciplinary team that includes a surgical gastroenterologist or hepatopancreato-biliary (HPB) surgeon, a medical oncologist, and a radiation oncologist. Gastroenterologists with expertise in endoscopic ultrasound often play a key role in diagnosis and staging.

When comparing providers, look for a surgeon or centre with documented experience in complex pancreatic operations (including high-volume Whipple procedures), access to a formal multidisciplinary tumour board, and the ability to coordinate chemotherapy and radiation as part of an integrated plan. Clarity on post-operative follow-up, surveillance imaging schedules, and access to palliative or supportive care services is equally important to ask about.

Share a concise medical summary, symptom timeline, previous diagnoses, investigation and imaging reports, procedure or biopsy reports where relevant, current medicines, allergies and related treatment records. Provide clear copies with translations when needed. The reviewing doctor may request additional information before giving an opinion.

Our care coordination team can review the initial information, help identify suitable doctors and hospitals, request a medical opinion where available, explain next steps and indicative cost information, and support practical planning before travel. A remote opinion does not replace an in-person examination or emergency care.